GPA
ZBH icon

Guidance Point Advisors’s Zimmer Biomet ZBH Stock Holding History

Guidance Point Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-53
Closed -$6K – 424
2021
Q3 		$6K Buy
+53
New +$7.8K ﹤0.01% 320

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Guidance Point Advisors's ZBH Position: Q4 2021 in Review

Guidance Point Advisors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 53 shares — an estimated $6K sold.

Guidance Point Advisors first reported a position in ZBH in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Guidance Point Advisors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Guidance Point Advisors sold 53 Zimmer Biomet shares in Q4 2021, an estimated $6K.
  • Guidance Point Advisors first reported a position in Zimmer Biomet in Q3 2021 and held it in 1 quarter.
  • Guidance Point Advisors's Zimmer Biomet position peaked at $6K in Q3 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.